Last reviewed · How we verify
COVID-19 treatment
Approved treatments
- Combination BNT162b2 and BNT162b2 OMI · Pfizer
A combination of two mRNA-based vaccines that work together to prevent and treat COVID-19. - BNT162b2 · Pfizer
- BNT162b5 Bivalent (Original/OMI BA.4/BA.5) · Pfizer
Targets the SARS-CoV-2 virus to prevent and treat COVID-19 - BNT162b2 (Omi JN.1) · Pfizer
- Famtozinameran 12 Years of age and older · Pfizer
Famtozinameran works by targeting the SARS-CoV-2 virus. - BNT162b2 (2025/2026 formulation) · Pfizer
- BNT162b2 OMI · Pfizer
- qIRV (22/23) · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- COVID-19 treatment patent landscape — cliff calendar, originator estates, attackable patents
- COVID-19 treatment treatment landscape brief
- COVID-19 treatment treatment updates RSS
Frequently asked questions about COVID-19 treatment
What drugs treat COVID-19 treatment?
Tracked treatments include Combination BNT162b2 and BNT162b2 OMI, BNT162b2, BNT162b5 Bivalent (Original/OMI BA.4/BA.5), BNT162b2 (Omi JN.1), Famtozinameran 12 Years of age and older, BNT162b2 (2025/2026 formulation), BNT162b2 OMI, qIRV (22/23).
What is the treatment for COVID-19 treatment?
Standard treatment for COVID-19 treatment includes Combination BNT162b2 and BNT162b2 OMI, BNT162b2, BNT162b5 Bivalent (Original/OMI BA.4/BA.5), BNT162b2 (Omi JN.1), Famtozinameran 12 Years of age and older. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: COVID-19 treatment patent cliff · COVID-19 treatment CI report
- Treatment: Combination BNT162b2 and BNT162b2 OMI · Pfizer
- Treatment: BNT162b2 · Pfizer
- Treatment: BNT162b5 Bivalent (Original/OMI BA.4/BA.5) · Pfizer
- Treatment: BNT162b2 (Omi JN.1) · Pfizer
- Treatment: Famtozinameran 12 Years of age and older · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing